Search Results - "VERDONCK, L. F"

Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival by KERSTING, S, KOOMANS, H. A, HENE, R. J, VERDONCK, L. F

“…Acute renal failure (ARF) is an important complication after stem cell transplantation (SCT). We retrospectively analysed ARF in 363 recipients of allogeneic…”
Get full text

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia by HUISMAN, C, DE WEGER, R. A, DE VRIES, L, TILANUS, M. G. J, VERDONCK, L. F

“…The role of chimerism analysis as a prognostic indicator of relapse after hematopoietic stem cell transplantation (SCT) is controversial. We monitored…”
Get full text

Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome by LOKHORST, H. M, SCHATTENBERG, A, CORNELISSEN, J. J, VAN OERS, M. H. J, FIBBE, W, RUSSELL, I, DONK, N. W. C. J. V. D, VERDONCK, L. F

“…To determine the efficacy, toxicity, and long-term outcome and prognostic factors of donor lymphocyte infusions (DLI) in patients with relapsed multiple…”
Get full text

Donor Leukocyte Infusions Are Effective in Relapsed Multiple Myeloma After Allogeneic Bone Marrow Transplantation by Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L.M., Verdonck, L.F.

“…Donor leukocyte infusions (DLI) can induce sustained remissions in patients with acute and chronic myeloid leukemia who relapse after allogeneic bone marrow…”
Get full text

Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation by MANDIGERS, C. M. P. W, VERDONCK, L. F, MEIJERINK, J. P. P, DEKKER, A. W, SCHATTENBERG, A. V. M. B, RAEMAEKERS, J. M. M

“…Donor lymphocyte infusions (DLI) are used to treat relapsed haematological diseases after allogeneic stem cell transplantation (SCT). We treated seven patients…”
Get full text

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia by Lodewyck, T, Oudshoorn, M, van der Holt, B, Petersen, E, Spierings, E, von dem Borne, P A, Schattenberg, A, Allebes, W, Groenendijk-Sijnke, M, Duinhouwer, L, Willemze, R, Lowenberg, B, Verdonck, L F, Meijer, E, Cornelissen, J J

“…Many parameters predict for outcome after unrelated donor (URD) allogeneic hematopoietic stem cell transplantation (alloSCT). High-resolution HLA-matching…”
Get full text

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants by GAHRTON, G, IACOBELLI, S, KRÖGER, N, LJUNGMAN, P, MICHALLET, M, RUSSELL, N. H, SAMSON, D, SCHATTENBERG, A, SIROHI, B, VERDONCK, L. F, VOLIN, L, ZANDER, A, APPERLEY, J, NIEDERWIESER, D, BANDINI, G, BJÖRKSTRAND, B, BLADE, J, BOIRON, J. M, CAVO, M, CORNELISSEN, J, CORRADINI, P

“…The impact of the donor gender on outcome in HLA-identical sibling donor hematopoietic stem cell transplantation for multiple myeloma was studied in a…”
Get full text

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma by VAN DE DONK, N. W. C. J, KRÖGER, N, AYUK, F. A, VAN OERS, M. H. J, NAGLER, A, VERDONCK, L. F, LOKHORST, H. M, HEGENBART, U, CORRADINI, P, SAN MIGUEL, J. F, GOLDSCHMIDT, H, PEREZ-SIMON, J. A, ZIJIMANS, M, RAYMAKERS, R. A, MONTEFUSCO, V

“…In this retrospective study, we evaluated donor lymphocyte infusions given for relapsed (n=48) or persistent (n=15) myeloma following non-myeloablative…”
Get full text

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres by Gahrton, G., Svensson, H., Cavo, M., Apperley, J., Bacigalupo, A., Björkstrand, B., Bladé, J., Cornelissen, J., De Laurenzi, A., Facon, T., Ljungman, P., Michallet, M., Niederwieser, D., Powles, R., Reiffers, J., Russell, N. H., Samson, D., Schaefer, U. W., Schattenberg, A., Tura, S., Verdonck, L. F., Vernant, J. P., Willemze, R., Volin for the European Group for Blood, L.

“…Out of 690 allogeneic matched sibling donor transplants for multiple myeloma reported to the European Group for Blood and Marrow Transplantation (EBMT)…”
Get full text

Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT by Chevallier, P, Labopin, M, Nagler, A, Ljungman, P, Verdonck, L F, Volin, L, Zander, A R, Finke, J, Socie, G, Cordonnier, C, Harousseau, J-L, Mohty, M, Rocha, V

“…The aim of this multicenter retrospective analysis was to carry out a survey of overall outcomes after allo-hematopoietic SCT of AML patients harboring trisomy…”
Get full text

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma : A retrospective case-matched study from the European group for blood and marrow transplantation by BJÖRKSTRAND, B, LJUNGMAN, P, GOLDSTONE, A. H, DE LAURENZI, A, MAJOLINO, I, MARCUS, R, PRENTICE, H. G, REMES, K, SAMSON, D, SUREDA, A, VERDONCK, L. F, VOLIN, L, SVENSSON, H, GAHRTON, G, HERMANS, J, ALEGRE, A, APPERLEY, J, BLADE, J, CARLSON, K, CAVO, M, FERRANT, A

“…A retrospective case-matched analysis was performed comparing 189 myeloma patients treated with allogeneic bone marrow transplantation (allo-BMT) with an equal…”
Get full text

Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease by HUISMAN, C, VAN DER STRAATEN, H. M, CANNINGA-VAN DIJK, M. R, FIJNHEER, R, VERDONCK, L. F

“…Lung injury limits the success of allogeneic stem cell transplantation (SCT). The overall incidence varies from 30 to 50% and non-infectious causes occur in…”
Get full text

Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma by Verdonck, Leo F, van Putten, Wim L.J, Hagenbeek, Anton, Schouten, Harry C, Sonneveld, Pieter, van Imhoff, Gustaaf W, Kluin-Nelemans, Hanneke C, Raemaekers, John M.M, van Oers, Rien H.J, Haak, Hans L, Schots, Rik, Dekker, Adriaan W, de Gast, Gijsbert C, Löwenberg, Bob

“…Combination chemotherapy can cure about 45 percent of patients with disseminated intermediate-grade or high-grade non-Hodgkin's lymphoma. 1 Several…”
Get full text

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years by Cornelissen, J J, Versluis, J, Passweg, J R, van Putten, W L J, Manz, M G, Maertens, J, Beverloo, H B, Valk, P J M, van Marwijk Kooy, M, Wijermans, P W, Schaafsma, M R, Biemond, B J, Vekemans, M-C, Breems, D A, Verdonck, L F, Fey, M F, Jongen-Lavrencic, M, Janssen, J J W M, Huls, G, Kuball, J, Pabst, T, Graux, C, Schouten, H C, Gratwohl, A, Vellenga, E, Ossenkoppele, G, Löwenberg, B

“…The preferred type of post-remission therapy (PRT) in patients with acute myeloid leukemia (AML) in first complete remission (CR1) is a subject of continued…”
Get full text

Infectious gastro-enteritis : an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients by VAN KRAAIJ, M. G. J, DEKKER, A. W, VERDONCK, L. F, VAN LOON, A. M, VINJE, J, KOOPMANS, M. P. G, ROZENBERG-ARSKA, M

“…The incidence and aetiology of acute diarrhoea in 60 adult allogeneic or autologous stem cell transplant (SCT) recipients was determined in a prospective…”
Get full text

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia by Löwenberg, B, Boogaerts, M A, Daenen, S M, Verhoef, G E, Hagenbeek, A, Vellenga, E, Ossenkoppele, G J, Huijgens, P C, Verdonck, L F, van der Lelie, J, Wielenga, J J, Schouten, H C, Gmür, J, Gratwohl, A, Hess, U, Fey, M F, van Putten, W L

“…The hematopoietic growth factors (HGFs) introduced into induction chemotherapy (CT) of acute myeloid leukemia (AML) might be of benefit to treatment outcome by…”
Get more information

Variable EBV DNA Load Distributions and Heterogeneous EBV mRNA Expression Patterns in the Circulation of Solid Organ versus Stem Cell Transplant Recipients by Greijer, A. E., Stevens, S. J., Verkuijlen, S. A., Juwana, H., Fleig, S. C., Verschuuren, E. A., Hepkema, B. G., Cornelissen, J. J., Brooimans, R. A., Verdonck, L. F., Middeldorp, J. M.

“…Epstein-Barr virus (EBV) driven post-transplant lymphoproliferative disease (PTLD) is a heterogeneous and potentially life-threatening condition. Early…”
Get full text

Allogeneic bone Marrow transplantation for low-grade lymphoma by VAN BESIEN, K, SOBOCINSKI, K. A, MCCARTHY, P. L, RAEMAEKERS, J. M. M, REIFFERS, J, PHILLIPS, G. L, SCHATTENBERG, A. V. M. B, VERDONCK, L. F, VOSE, J. M, HOROWITZ, M. M, ROWLINGS, P. A, MURPHY, S. C, ARMITAGE, J. O, BISHOP, M. R, CHAEKAL, O.-K, GALE, R. P, KLEIN, J. P, LAZARUS, H. M

“…Advanced low-grade lymphomas are usually incurable with conventional-dose chemotherapy. It is uncertain whether cures are possible with high-dose therapy and…”
Get full text

Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study by Vellenga, E., Van Agthoven, M., Croockewit, A. J., Verdonck, L. F., Wijermans, P. J., Van Oers, M. H. J., Volkers, C. P., Van Imhoff, G. W., Kingma, T., Uyl‐de Groot, C. A., Fibbe, W. E.

“…The present study analysed whether autologous peripheral blood stem cell transplantation (PSCT) improves engraftment, quality of life and cost‐effectiveness…”
Get full text

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma by Verdonck, Leo F., Dekker, Adriaan W., Lokhorst, Henk M., Petersen, Eefke J., Nieuwenhuis, H. Karel

“…Patients with recurrent or refractory low-grade non-Hodgkin's lymphoma (NHL) are increasingly treated with myeloablative therapy and autologous stem cell…”
Get full text